Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0016053 (fibromyalgia)
 4,687 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

Myofascial pain syndrome of the TMJ region is not uncommon. It is important to realize that these patients often have a history of TMJ trauma, frequently have positive physical findings of the TMJ, and often have positive roentgenographic findings which continue following successful therapy of myofascial pain syndrome mimicking pain of the TMJ. Because of this, the malady is often diagnosed as TMJ disease, refractory to treatment, rather than correctly as myofascial pain syndrome. Continued investigation of myofascial pain syndrome of the TMJ region is indicated.
 ...
PMID:Myofascial pain syndrome masquerading as temporomandibular joint pain. 26 34

Myofascial pain syndrome is a regional muscle pain disorder that is the most common physical diagnosis causing chronic pain. The complex symptoms, concomitant disorders, and frequent behavioral and psychosocial contributing factors make this disorder frequently overlooked and difficult to treat. Once recognized, management programs involving rehabilitating the affected muscles and controlling the contributing factors are effective if long-term compliance is maintained by the patient.
 ...
PMID:Myofascial pain syndrome. 265 82

Myofascial pain syndrome (MPS) is a common but misunderstood muscular pain disorder involving pain referred from small, tender trigger points within myofascial structures in or distant from the area of pain. Misdiagnosis or inadequate management of this disorder after onset may lead to development of a complex chronic pain syndrome. A review of the clinical characteristics of 164 patients whose chief complaints led to the diagnosis of MPS revealed that these patients had (1) tenderness at points in firm bands of skeletal muscle that were consistent with past reports, (2) specific patterns of pain referral associated with each trigger point, (3) frequent emotional, postural, and behavioral contributing factors, and (4) frequent associated symptoms and concomitant diagnoses.
 ...
PMID:Myofascial pain syndrome of the head and neck: a review of clinical characteristics of 164 patients. 386 33

Myofascial pain syndrome is an entity with which every podiatrist should be familiar. These disorders are usually the result of acute or chronic injury and are characterized by the presence of trigger areas and symptom complexes that have definite patterns. Once these patterns have been learned, the sources of pain can be readily predicted. Most of these conditions can be effectively treated in the podiatrist's office by local block techniques and/Or by application of Fluori-Methane spray. It is important to consult the appropriate medical specialist for diagnostic confirmation or for aid in treatment if uncertainty exists. Treatment regimens in this group of syndromes are based on the notion that in these disorders there is a self-sustaining cycle of pain-spasm-pain persisting after the precipitating cause has disappeared, which may be permanently abolished by interruption of the reflex mechanisms. In order to produce optimal results, the trigger area must be accurately located and treatment directed toward its elimination. Physical therapy and active exercise are necessary adjuncts to local blocks. Not all patients respond, and in many the response is slow, incomplete, and/or only temporary, but there are those in whom these simple measures provide relief of pain and disability in a manner as dramatic as one is likely to encounter in practice.
 ...
PMID:Myofascial pain syndromes and their effect on the lower extremities. 704 May 34

Myofascial pain syndrome (MPS) is one of the least understood yet commonly encountered problems in the outpatient setting. Myofascial pain syndrome is a painful disorder characterized by trigger points (TrPs), which are hyperirritable spots causing referred pain. Myofascial pain syndrome is frustrating to patients and clinicians. Unfortunately, MPS often goes unrecognized, misdiagnosed, or mistreated, leading to unnecessary pain, suffering, and disability. When treated properly, MPS has an excellent prognosis. Besides specific TrP therapy, treatment involves lifestyle changes and long-term management to prevent recurrences. A multidisciplinary approach utilizing primary care providers, physical therapists, occupational therapists, and other health care professionals is essential to correctly assess and treat MPS. Primary care providers knowledgeable about MPS are in a pivotal position to identify this disorder and to intervene appropriately.
 ...
PMID:Myofascial pain syndrome: a multidisciplinary approach. 759 28

The relation between reported chronic pain and clinical findings was studied by comparing survey data six months before and eighteen months after a clinical examination. Studied individuals (n = 165) were randomly selected from subsamples of an initial survey (n = 1806) to a general population. Among individuals reporting chronic pain 85% were assessed to have chronic pain at the examination. Diagnoses were found in 22% of examined pain individuals. Myofascial pain syndrome and myalgia were the most common findings. Compared with located neck-shoulder pain, widespread pain had a greater impact on the individual, a worse prognosis regarding pain duration and working capacity, and revealed a raised serum urate level of unclear significance. Although no specific cause of pain is found in individuals with widespread pain it is important to identify and treat this group due to the great effects on functional capacity and the worse prognosis.
 ...
PMID:Characteristics of subjects with chronic pain, in relation to local and widespread pain report. A prospective study of symptoms, clinical findings and blood tests in subgroups of a geographically defined population. 866 57

Myofascial pain syndrome of the head and neck is a frequent cause of facial pain and is characterized by tender trigger points. In a double-blind study of 107 patients, local injection therapy using one of three solutions was applied at the trigger points by intracutaneous injection of 0.3 ml solution followed by deep infiltration of the site. Results using bupivacaine 0.25%, lignocaine 1% and saline 0.9% were compared. There was no significant difference among groups with respect to reduction of pain and overall rating by patients of the therapeutic benefits. Fifty-three patients (49%) were free of symptoms after treatment, 40 patients (38%) reported substantial relief and in 14 patients (13%) symptoms remained unchanged. The findings suggest that relief of pain is mainly due to reflex mechanisms rather than to the pharmacological effects of the injected solutions. Physiological saline solution is recommended for use in local injection therapy.
 ...
PMID:Local injection therapy in 107 patients with myofascial pain syndrome of the head and neck. 895 38

Myofascial pain syndrome (MPS) is a very common localized--sometimes also polytopic--painful musculoskeletal condition associated with trigger points, for which, however, diagnostic criteria established in well-designed studies are still lacking. These two facts form the basis for differentiating between MPS and the fibromyalgia syndrome. The difference between trigger points (MPS) and tender points (fibromyalgia) is of central importance--not merely in a linguistic sense. A knowledge of the signs and symptoms typically associated with a trigger point often obviates the need for time-consuming and expensive technical diagnostic measures. The assumption that many cases of unspecific complaints affecting the musculoskeletal system may be ascribed to MPS makes clear the scope for the saving of costs.
 ...
PMID:[Myofascial pain syndrome--frequent occurrence and often misdiagnosed]. 981 49

Myofascial pain syndrome (MPS) is a common illness, characterised by acute or chronic focal pain, muscle stiffness and fatigue. The pathophysiology of MPS remains unclear. Previous preliminary studies have demonstrated therapeutic efficacy of the muscle relaxant botulinum toxin type A (BTX-A) in the treatment of MPS. A single-centre, randomised trial compared the effects of BTX-A with the steroid methylprednisolone (both administered intramuscularly with 0.5% bupivacaine), in 40 patients suffering from chronic myofascial pain in the piriformis, iliopsoas or scalenus anterior muscles. Thirty days after receiving an injection of either BTX-A or steroid followed by post-injection physiotherapy, pain severity had decreased significantly from baseline in both treatment groups, with no significant difference between the two treatment groups. However, the baseline pain score was significantly higher in the BTX-A treatment group compared with the steroid group (7.9 vs. 7.3), and the reduction in pain score between baseline and 30 days post-injection was greater in the BTX-A group compared with the steroid group (-3.9 vs. -3.5; P=0.06). At 60 days post-injection, the pain severity score for the BTX-A-treated patients was statistically significantly lower than the pain score for the steroid-treated population (2.3 vs. 4.9). Furthermore, the reduction in pain score in the BTX-A group at 60 days post-injection was greater than at 30 days (-5.5 vs. -3.9), whereas the effect of the steroid had begun to wane. These results indicate the superior efficacy of BTX-A over conventional steroid treatment in patients suffering from MPS, when combined with appropriate physiotherapy.
 ...
PMID:A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. 1069 8

Myofascial pain syndrome(MPS) is characterized by its unique pathology on developing the intramuscular trigger points. The author performed the psychological tests(Cornell Medical Index, Tokyo University Egogram, Minnesota Multiphasic Personality Inventory) on 46 MPS patients to clarify the psychological background. Results revealed that the MPS patients had remarkable hypochondriacal tendency with irrational way of thinking. The author concluded that it is necessary to be hypochondriacal and irrational for the formation of apparent MPS with outstanding TPs. This fact suggests that TPs in MPS are the result of deteriorated central pain control mechanism that should actually suppress the mechanical constriction of damaged muscles.
 ...
PMID:[Interrelation between physical disease and chronic pain--importance of understanding myofascial pain syndrome]. 1155 50


1 2 3 4 5 6 7 Next >>